Cognitive impairment is highly prevalent in patients with end-stage renal disease,and this impairment,which involves a range of cognitive domains including attention,memory,and executive functioning,severely diminishes patients'quality of life.However,the exact mechanisms underlying this neurocognitive deficit are unknown,making it challenging to detect and manage this cognitive impairment at an early stage.Multimodal magnetic resonance imaging has yielded many results in this area in recent years and holds the promise of selecting imaging biomarkers to guide early screening and diagnosis of cognitive deficits in patients with chronic kidney disease(CKD).This paper will briefly describe the research progress of various emerging MRI technologies and artificial intelligence in end-stage renal disease(ESRD)patients with cognitive impairment,and try to reveal the connection between brain structure,function,perfusion,metabolism,neurovascular coupling and cognitive dysfunction in ESRD patients,so as to help clinical understanding of the potential neuronal mechanism of brain defects in ESRD patients.It is beneficial to the early diagnosis,treatment and follow-up of ESRD patients with cognitive impairment.
维普
万方数据